Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase NA 3Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Neoplasms 3Colorectal Neoplasms 3Colonic Neoplasms 3Uterine Cervical Dysplasia 1Stomatitis 1Rectal Neoplasms 1Pain 1Neurofibromatosis 1 1Lung Neoplasms 1Castration Sensitive Prostate Cancer 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Paclitaxel 81Trastuzumab 76Fulvestrant 55Cyclophosphamide 49Capecitabine 42Lapatinib 40pembrolizumab 38Docetaxel 38palbociclib 36Carboplatin 32Letrozole 28olaparib 23Doxorubicin 23Gemcitabine 21Taxes 20Everolimus 20ribociclib 19abemaciclib 19Ado-Trastuzumab Emtansine 18pertuzumab 17Radiotherapy 17Magnetic Resonance Spectroscopy 17Bevacizumab 16130-nm albumin-bound paclitaxel 16exemestane 15Vinorelbine 15Cisplatin 15veliparib 14Biopsy 14Alpelisib 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Breast Neoplasms × Curcumin × Clear all
NCT03980509 2025-01-30

A "Window Trial" on Curcumin for Invasive Breast Cancer Primary Tumors

Medical University of South Carolina

Phase 1 Completed
22 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡